Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan for reduction of portal pressure in cirrhosis
2007-005679-33Phase 2Terminated
- Sponsor
- Martin Luther University Halle-Wittenberg Medical Faculty
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambrisentan in Portal Hypertension (PH), Cirrhosis, sponsored by Martin Luther University Halle-Wittenberg Medical Faculty. Started Oct 2010; status: terminated.
02
Drugs
ambrisentan
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on 2007-005679-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005679-33.